{"effective_time":"20171213","id":"66e5c916-70e4-40b9-96e1-aecc9825074a","openfda":{},"package_label_principal_display_panel":["PACKAGE/LABEL PRINCIPAL DISPLAY PANEL NDC 67457-598-05 Etoposide Injection, USP 100 mg/5 mL (20 mg/mL) Must be diluted before intravenous infusion CAUTION:CYTOTOXIC AGENT Sterile Mylan Rx only Multiple-Dose vial Carton"],"package_label_principal_display_panel_table":["<table width=\"100%\"> <col width=\"100%\"/> <tbody> <tr> <td valign=\"top\" styleCode=\"Rrule Botrule Lrule Toprule \"> <paragraph> <content styleCode=\"bold\">CAUTION:CYTOTOXIC AGENT</content> </paragraph> </td> </tr> </tbody> </table>"],"set_id":"66e5c916-70e4-40b9-96e1-aecc9825074a","spl_product_data_elements":["ETOPOSIDE ETOPOSIDE ETOPOSIDE ETOPOSIDE ANHYDROUS CITRIC ACID BENZYL ALCOHOL POLYSORBATE 80 POLYETHYLENE GLYCOL 300 ALCOHOL"],"version":"1"}